Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell linesNarendra Wajapeyee(University of Alabama at Birmingham), Michael R. Green(Dana-Farber Cancer Institute)Molecular Cancer TherapeuticsOctober 27, 200910.1158/1535-7163.mct-09-0470Cited by 46SaveCiteExport RISWatch citationsRelated PapersIntegrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma|Blood|2010|1.3kA single polypyrimidine tract binding protein (PTB) binding site mediates splicing inhibition at mouse IgM exons M1 and M2|RNA|2004|58Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells|Cell Reports Medicine|2023|40Transcription and signalling pathways involved in BCR–ABL‐mediated misregulation of 24p3 and 24p3R|The EMBO Journal|2009|39SMARCA4 is a haploinsufficient B cell lymphoma tumor suppressor that fine-tunes centrocyte cell fate decisions|Cancer Cell|2024|28